InvestorsHub Logo
Followers 95
Posts 9573
Boards Moderated 2
Alias Born 03/25/2013

Re: Lenard post# 111

Monday, 01/28/2019 12:03:59 PM

Monday, January 28, 2019 12:03:59 PM

Post# of 632
Avalon GloboCare and its Subsidiary Genexosome Technologies Announce Discovery and Development of World’s First Saliva-Based Exosomal Biomarker “miR-185” as Dual Diagnostic and Therapeutic Target for Oral Cancer

https://globenewswire.com/news-release/2019/01/28/1706078/0/en/Avalon-GloboCare-and-its-Subsidiary-Genexosome-Technologies-Announce-Discovery-and-Development-of-World-s-First-Saliva-Based-Exosomal-Biomarker-miR-185-as-Dual-Diagnostic-and-Thera.html

JMHO. DYODD. "An investment in knowledge pays the best interest." - Benjamin Franklin

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALBT News